The partnership will focus on research, training, and knowledge exchange in genetics and healthcare
L – R: Dr Satyaprakash Pandey, Senior Scientist, TIGS, Dr Gayatri R Iyer, Scientist, TIGS, Dr Saroj Kumar Sabath, Associate Vice President – Regulatory, Max Healthcare, Dr Rakesh Mishra, Director, TIGS, Dr Sandeep Budhiraja, Group Medical Director, Max Healthcare, Dr Nitin Dayal, Associate Director & Chief – Haemato Pathology and Immuno Haematology, Max Healthcare, Dr Manish Malik, Director, Paediatrics – NICU, Dr Vinitaa Jha, Director – Research and Academics, Max Healthcare, Jatin Sharma, Senior Executive – Legal, Max Healthcare, Dr Poorvee Mathur, General Manager – Grants, Partnerships, and New Initiatives, Max Healthcare.
Max Healthcare, a private sector healthcare services company in India, and the Tata Institute for Genetics and Society (TIGS), a genomics research institute, have signed a Memorandum of Understanding (MoU). The agreement establishes a collaborative platform for research, training, and knowledge exchange in genetics and healthcare, with a shared goal of supporting patient outcomes and clinical science.
The MoU was signed at a ceremony attended by representatives from both organisations. The partnership will focus on applying genomic research to healthcare challenges. Areas of collaboration will include joint research in rare genetic diseases, a focus on neonatal care using genomic insights, and the development of personalised medicine based on genetic profiling.
The collaboration includes opportunities for knowledge exchange between scientists, clinicians, and researchers from both organisations. Activities will include conferences, workshops, and training programmes. Max Healthcare will contribute clinical expertise and patient data, while TIGS will contribute genomics research capabilities. The partnership aims to support the application of research findings in clinical settings.
Dr Sandeep Budhiraja, Group Medical Director at Max Healthcare, said, “This partnership with the Tata Institute for Genetics and Society is a significant step forward in our commitment to bringing the latest advancements in medical sciences to our patients. By integrating genomics into our clinical practice, we can move towards a future of more personalised and effective healthcare. This collaboration will undoubtedly enhance our capabilities in clinical research and innovation, ultimately benefiting our patients and the broader healthcare landscape in India.”
Dr Rakesh Mishra, Director, Tata Institute for Genetics and Society, said, “At TIGS, our mission is to use cutting-edge science to solve societal problems. This collaboration with Max Healthcare provides a unique opportunity to apply our expertise in genomics to real-world clinical challenges. By working closely with clinicians and patients at Max Healthcare, we can ensure that our research is relevant, impactful, and translates into tangible benefits for society.”
The collaboration will involve work in genetics related to haematology and neonatal care. The partnership aims to expand understanding of the genetic basis of blood disorders, cancers, and neonatal conditions. The organisations aim to support diagnosis, personalised treatment approaches, and early identification of genetic risk factors in newborns.